Our preliminary results had shown an association of LAG3 promoter hypomethylation with increased levels of tumor infiltrating immune cells, whereas infiltration of immune cells was correlated with hypermethylation of the downstream CTCF binding site. The gene discussed is LAG3; the disease is neoplasm.